ASCVD remains a leading cause of morbidity and mortality, with secondary prevention critical to reducing recurrent events. Using the latest Australian and international guidelines, our cardiology and GP experts will explore the rationale for updated LDL-C targets. How low is too low? What new risk management tools and therapies should GPs be using, and why? What should GPs manage within in their practice and when should they consider referral?
Presented by GP Dr Rob Hungerford, and cardiologist A/Prof Adam Nelson, this deep-dive advanced course will provide you the latest evidence-based strategies to optimise cardiovascular secondary prevention in primary care.
Learning outcomes
Presenters
Dr Hungerford is a GP supervisor at a large teaching general practice in Newcastle and a rapid-access GP clinic at the John Hunter Hospital. He is a Tony Buhagiar Medal recipient, and has completed the Certificate of Excellence in Lipidology from the European Atherosclerosis Society. He is also a conjoint lecturer at the University of Newcastle, a Clinical Council member in the Australian Atherosclerosis Society, and is regularly involved with education at various levels in ASCVD, heart failure and diabetes.
A/Prof Nelson is an early career interventional cardiologist and clinical triallist with academic and clinical interests in dyslipidaemia, obesity and diabetes.
Related content
